Novo Holdings A/S's Form 4 filing
Spruce Biosciences, Inc. (SPRB) · filed Mar 20, 2024
- Accession no.
- 0001209191-24-005017
- Filed
- Mar 20, 2024
- Trade date
- Mar 18-20, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.36M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Novo Holdings A/SCIK 0001388325 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | COMMON STOCK | SSaleDisposed | −842,020 | $0.77 | −$648,355.4 | 3,968,000 | Direct | |
| Mar 19, 2024 | COMMON STOCK | SSaleDisposed | −593,000 | $0.76 | −$450,680 | 3,375,000 | Direct | |
| Mar 20, 2024 | COMMON STOCK | SSaleDisposed | −359,979 | $0.73 | −$262,784.67 | 3,015,021 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.